Oncimmune Holdings plc (AIM:ONC.L)

https://www.oncimmune.com

Oncimmune is a leader in the development, manufacture and commercialisation of cancer specific immunodiagnostics for the screening, detection and care of cancer. Oncimmune is working to change how cancer is diagnosed and treated. Its patented technology detects evidence of the body's natural response to cancer, enabling detection four years or more before standard clinical diagnosis. Oncimmune's tests facilitate clinical decision-making and are complementary to diagnostic technologies, making them valuable additions to established and new care pathways. Oncimmune partners with leading developers and distributors to make our technology available globally. Oncimmune was founded in 2002 and launched its platform technology in 2009, followed by its first commercial tests, EarlyCDT-Lung and EarlyCDT-Liver. To date, over 155,000 tests have been performed for patients worldwide and EarlyCDT-Lung is being used in the largest-ever randomised trial for the early detection of lung cancer using biomarkers, the National Health Service (NHS) ECLS study of 12,210 high-risk smokers in Scotland. Oncimmune, headquartered in Nottingham, UK has a CLIA lab in Kansas, US and offices in London, UK and Shanghai, China. Oncimmune joined the Alternative Investment Market (AIM) of the London Stock Exchange in May 2016 under the ticker ONC.L. *

	Start	2015-11-19 established
	Group	Freenome (Group)
	Predecessor	Oncimmune Ltd.
	Industry	diagnostics (medical/biological)
	Person	Hill, Adam M. (Oncimmune 201810– CEO joined 201803 before McLaren Applied Technologies)

	Region	Nottingham, Nottinghamshire
	Country	United Kingdom (GB)
	Street	1 Thane Road MediCity Nottingham, D6 Building
	City	NG90 6BH Nottingham
	Tel	+44-1157-840-500
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: Oncimmune Holdings plc. (3/19/19). "Press Release: Oncimmune Announces the Acquisition of Protagen Diagnostics AG, a Leader in Personalised Immuno-Profiling". Cambridge, MA.

		Record changed: 2023-07-10